• Bradford Protein Assay Kit: Practical Workflow

  2026-08-18

  The Bradford Protein Assay Kit (SKU K4103) provides rapid protein concentration measurement for soluble samples used in enzyme assays, purification, and molecular biology. It is best used with compatible, low-interference matrices and should be avoided for high-detergent samples or peptides with insufficient basic or aromatic residues.

• A 83-01 (ALK Inhibitor) for Organoid Research

  2026-08-18

  A 83-01 enables controlled TGF-β pathway perturbation in EMT, fibrosis, growth-inhibition, and intestinal organoid assays. Its value is greatest when paired with hiPSC-derived intestinal models that separate 3D expansion from 2D pharmacokinetic testing.

• EZ Cap Cy5 Firefly Luciferase mRNA Workflow

  2026-08-17

  Track where an mRNA formulation goes with Cy5, then measure whether it produces functional protein with Firefly Luciferase. This dual-readout design helps separate delivery, intracellular persistence, and translation in transfection, carrier-screening, and imaging studies.

• 3-Bromopyruvate Reverses Cetuximab Resistance in CRC

  2026-08-17

  The reference study shows that combining 3-bromopyruvate with cetuximab can suppress colorectal cancer models that are intrinsically or adaptively cetuximab-resistant. Its central mechanistic contribution is the connection of FOXO3a restoration with AMPKα–Beclin1 signaling, PUMA activation, autophagy-dependent ferroptosis, and apoptosis.

• Z-IETD-FMK in Reliable Cell Death Assays

  2026-08-16

  Learn how Z-IETD-FMK (SKU B3232) can help researchers separate caspase-8-dependent apoptosis from general loss of viability, immune-cell activation effects, and downstream pyroptotic signaling. This scenario-based guide covers assay controls, stock preparation, interpretation, and practical product-selection criteria.

• Dexamethasone (DHAP) in Translational Inflammation

  2026-08-15

  Dexamethasone (DHAP) is more than a broad anti-inflammatory control: it can function as a mechanistic anchor across NF-κB signaling, stem cell differentiation, autophagy, osteosarcoma, and neuroinflammation workflows. This article connects recent rosemary-root natural-product findings with practical strategies for using a defined glucocorticoid anti-inflammatory in translational research.

• RP3-340N1.2, IL-6, and NSCLC Progression

  2026-08-14

  This study identifies the long non-coding RNA RP3-340N1.2 as a post-transcriptional regulator of IL-6 mRNA stability in non-small cell lung cancer. By combining RNA sequencing, gene-perturbation experiments, RNA decay analysis, RNA immunoprecipitation, and tumor–macrophage co-culture, the authors connect RP3-340N1.2 to malignant behavior and microenvironmental signaling.

• Coumestrol Drives PMAIP1-Linked Ferroptosis in RA

  2026-08-14

  A 2026 study identifies a mechanistic link between Coumestrol, mitochondrial PMAIP1 stabilization, and ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes. The work suggests that redirecting the abnormal survival and inflammatory behavior of RA-FLS may complement conventional immune-focused strategies, while remaining an in vitro finding that requires further validation.

• NHS-Biotin for Reliable Cell Assay Readouts

  2026-08-13

  This scenario-driven guide explains how NHS-Biotin (SKU A8002) can add reproducible protein-level information to cell viability, proliferation, and cytotoxicity workflows without being mistaken for a direct viability reagent. It covers compatibility, practical labeling parameters, streptavidin-based interpretation, and vendor-selection criteria.

• Palmitic acid (N2456): Protocols and QC

  2026-08-13

  Palmitic acid (SKU N2456), also called hexadecanoic acid, provides a characterized saturated long-chain fatty acid for controlled studies of lipid handling, signaling, and related cellular responses. It is suitable for solvent-based preparation but should not be used directly in aqueous systems or for workflows requiring long-term storage of prepared solutions.

• BIRB 796 (Doramapimod) in p38α Research

  2026-08-12

  BIRB 796 (Doramapimod) combines strong p38α selectivity with an allosteric mechanism suited to inflammation, cytokine, and apoptosis workflows. This guide translates its molecular behavior into practical dosing, dephosphorylation, assay-control, and troubleshooting strategies.

• CHIR-99021 (CT99021) Stem Cell Workflow Guide

  2026-08-12

  Use CHIR-99021 (CT99021) as a timed GSK-3 perturbation rather than a one-size-fits-all additive for pluripotency, cardiac differentiation, and neuronal assays. This workflow connects Wnt/β-catenin pathway control with isoform-aware TRIM46 measurements to improve interpretation of axon-formation experiments.

• TAK1–YAP Control of Gastric Cancer Stem Cells

  2026-08-11

  The reference study identifies a mechanistic pathway in which IL-6-induced TAK1 stabilizes YAP and supports SOX2/SOX9-dependent self-renewal and oncogenesis of gastric cancer stem cells. Its combination of tissue profiling, functional perturbation, molecular interaction analysis, and in vivo validation provides a framework for studying how inflammatory signaling sustains therapy-relevant tumor cell populations.

• Proteinase K for DNA Workflows and Protease Assays

  2026-08-11

  Proteinase K combines broad protein hydrolysis with compatibility across detergents, chelators, and DNA-preserving workflows. This guide shows how to use it for genomic DNA isolation, enzyme contaminant removal, assay controls, and practical troubleshooting while applying lessons from a SARS-CoV-2 protease inhibitor study.

• Drug-Response Metrics in Cancer In Vitro

  2026-08-10

  Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell killing are related but non-equivalent components of an in vitro drug response. The framework supports more informative cancer drug assays by pairing endpoint measurements with attention to response magnitude and timing.

16913 records 1/1128 page Next 12345 下5页 Last page